SFX by Ex Libris Inc.

Title:	Rational HIV immunogen design to target specific germline B cell receptors
Source:	Science [0036-8075] Jardine, J yr:2013

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ploquin, A. "Protection Against Henipavirus Infection Using Recombinant AAV Vector Vaccines." The Journal of infectious diseases 207.3 (2012): 469-78.
description	2.	Julien, J. "Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA." Immunological reviews 250.1 (2012): 180-198.
description	3.	Diskin, R. "Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design." Science 334.6060 (2011): 1289-1293.
description	4.	Arnott, A. "High Viral Fitness during Acute HIV-1 Infection." PLoS ONE 5.9 (2010): 1-12.
description	5.	Henghold WB 2nd, W.B. B. "Other biologic toxin bioweapons: ricin, staphylococcal enterotoxin B, and trichothecene mycotoxins." Dermatologic clinics 22.3 (2004): 257-262.
description	6.	Wilson, U. "A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield." Science 334.6059 (2011): 1097-1103.
description	7.	Field, Hume E. "The Application of One Health Approaches to Henipavirus Research." Current Topics in Microbiology and Immunology (2012): 155-170.
description	8.	Lindsay, D S. "Development of Sarcocystis falcatula in cell cultures demonstrates that it is different from Sarcocystis neurona." Parasitology 118.3 (1999): 227-233.
description	9.	Noar, Seth M. "eHealth interventions for HIV prevention." AIDS care 24.8 (2012): 945-952.
description	10.	Brockman, Mark A. "Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated in chronic infection." Journal of virology 84.22 (2010): 11937-11949.
description	11.	Zhan, P. "Targeting Protein-Protein Interactions: A Promising Avenue of Anti-HIV Drug Discovery." Current Medicinal Chemistry 17.29 (2010): 3393-3409.
description	12.	Tobin, G. "Deceptive imprinting and immune refocusing in vaccine design." Vaccine 26.49 (2008): 6189-6199.
description	13.	Varghese, B. "Generation of CD8+ T cell-mediated immunity against idiotype-negative lymphoma escapees." Blood 114.20 (2009): 4477-4485.
description	14.	Glynn, Peter W. "Acanthaster: Effect on Coral Reef Growth in Panama." Science 180.4085 (1973): 504-506.
description	15.	Ekiert, D. "Antibody Recognition of a Highly Conserved Influenza Virus Epitope." Science 324.5924: 246-51.
description	16.	HUBER, R. "STRUCTURAL BASIS FOR ANTIGEN-ANTIBODY RECOGNITION." Science 233.4765 (1986): 702-703.
description	17.	Perno CF. "HIV fitness and resistance as covariates associated with the appearance of mutations under antiretroviral treatment." Scandinavian journal of infectious diseases. Supplementum 35 Suppl 106 (2003): 37-40.
description	18.	Greenberg, Michael I I. "Toxins: bacterial and marine toxins." Clinics in laboratory medicine 26.2 (2006): 397-419.
description	19.	Percus, Jerome K. "The distribution of viral blips observed in HIV-1 infected patients treated with combination antiretroviral therapy." Bulletin of mathematical biology 65.2 (2003): 263-277.
description	20.	Carrat, F. "Influenza vaccine: The challenge of antigenic drift." Vaccine 25.39-40 (2007): 6852-6862.